Valeo Financial Advisors, LLC Fulgent Genetics, Inc. Transaction History

Valeo Financial Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$47.98 - $62.75 $72,593 - $94,940	-1,513 Reduced 18.7%	6,577 $359,000
Q1 2022 Apr 28, 2022	SELL	$49.85 - $96.11 $24,576 - $47,382	-493 Reduced 5.74%	8,090 $505,000
Q4 2021 Jan 07, 2022	BUY	$77.3 - $105.0 $50,167 - $68,145	649 Added 8.18%	8,583 $863,000
Q2 2021 Jul 22, 2021	BUY	$66.8 - $100.45 $18,971 - $28,527	284 Added 3.71%	7,934 $732,000
Q1 2021 Apr 12, 2021	BUY	$59.3 - $183.85 $230,973 - $716,095	3,895 Added 103.73%	7,650 $739,000
Q4 2020 Feb 11, 2021	BUY	$31.01 - $52.1 $15,505 - $26,050	500 Added 15.36%	3,755 $196,000
Q3 2020 Oct 28, 2020	BUY	$15.89 - $50.51 $30,318 - $96,373	1,908 Added 141.65%	3,255 $130,000
Q2 2020 Jul 20, 2020	SELL	$8.89 - $18.28 $2,000 - $4,113	-225 Reduced 14.31%	1,347 $22,000
Q1 2020 Apr 13, 2020	BUY	$6.75 - $19.75 $4,475 - $13,094	663 Added 72.94%	1,572 $17,000
Q4 2019 Jan 24, 2020	BUY	$9.29 - $15.82 $8,444 - $14,380	909 New	909 $12,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.